DK1902054T3 - Pyrido[2,3-d]pyrimidinderivater, fremstilling og terapeutisk anvendelse heraf - Google Patents

Pyrido[2,3-d]pyrimidinderivater, fremstilling og terapeutisk anvendelse heraf

Info

Publication number
DK1902054T3
DK1902054T3 DK06778710T DK06778710T DK1902054T3 DK 1902054 T3 DK1902054 T3 DK 1902054T3 DK 06778710 T DK06778710 T DK 06778710T DK 06778710 T DK06778710 T DK 06778710T DK 1902054 T3 DK1902054 T3 DK 1902054T3
Authority
DK
Denmark
Prior art keywords
pyrido
preparation
therapeutic use
pyrimidine derivatives
pyrimidine
Prior art date
Application number
DK06778710T
Other languages
Danish (da)
English (en)
Inventor
Claude Muneaux
Pierre Casellas
Pierre Perreaut
Samir Jegham
Bernard Bourrie
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Application granted granted Critical
Publication of DK1902054T3 publication Critical patent/DK1902054T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK06778710T 2005-07-01 2006-06-29 Pyrido[2,3-d]pyrimidinderivater, fremstilling og terapeutisk anvendelse heraf DK1902054T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0507032A FR2887882B1 (fr) 2005-07-01 2005-07-01 Derives de pyrido[2,3-d] pyrimidine, leur preparation, leur application en therapeutique
PCT/FR2006/001518 WO2007003765A1 (fr) 2005-07-01 2006-06-29 DERIVES DE PYRIDO[2,3-d]PYRIMIDINE, LEUR PREPARATION, LEUR APPLICATION EN THERAPEUTIQUE

Publications (1)

Publication Number Publication Date
DK1902054T3 true DK1902054T3 (da) 2009-06-15

Family

ID=36096420

Family Applications (2)

Application Number Title Priority Date Filing Date
DK06778710T DK1902054T3 (da) 2005-07-01 2006-06-29 Pyrido[2,3-d]pyrimidinderivater, fremstilling og terapeutisk anvendelse heraf
DK08017944.3T DK2020410T3 (en) 2005-07-01 2006-06-29 Pyrido [2,3-d] pyrimidine derivatives, the preparation thereof and therapeutic use

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK08017944.3T DK2020410T3 (en) 2005-07-01 2006-06-29 Pyrido [2,3-d] pyrimidine derivatives, the preparation thereof and therapeutic use

Country Status (41)

Country Link
US (2) US7504406B2 (el)
EP (2) EP1902054B1 (el)
JP (1) JP4472009B2 (el)
KR (1) KR101298344B1 (el)
CN (2) CN101213196B (el)
AR (1) AR054812A1 (el)
AT (1) ATE423119T1 (el)
AU (1) AU2006264801B2 (el)
BR (1) BRPI0613020A2 (el)
CA (1) CA2610794C (el)
CR (1) CR9568A (el)
CY (2) CY1110457T1 (el)
DE (1) DE602006005246D1 (el)
DK (2) DK1902054T3 (el)
DO (1) DOP2006000145A (el)
EA (1) EA014312B1 (el)
EC (1) ECSP078011A (el)
ES (2) ES2322101T3 (el)
FR (1) FR2887882B1 (el)
HK (1) HK1122797A1 (el)
HR (2) HRP20090236T1 (el)
IL (1) IL187900A0 (el)
JO (1) JO2550B1 (el)
MA (1) MA29561B1 (el)
ME (1) ME01813B (el)
MX (1) MX2007016239A (el)
MY (1) MY143089A (el)
NO (1) NO20080418L (el)
NZ (1) NZ564072A (el)
PA (1) PA8684801A1 (el)
PE (1) PE20070139A1 (el)
PL (2) PL1902054T3 (el)
PT (2) PT1902054E (el)
RS (2) RS50781B (el)
SI (2) SI1902054T1 (el)
TN (1) TNSN07440A1 (el)
TW (1) TWI321566B (el)
UA (1) UA92021C2 (el)
UY (1) UY29645A1 (el)
WO (1) WO2007003765A1 (el)
ZA (1) ZA200711032B (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2873118B1 (fr) 2004-07-15 2007-11-23 Sanofi Synthelabo Derives de pyrido-pyrimidine, leur application en therapeutique
FR2887882B1 (fr) * 2005-07-01 2007-09-07 Sanofi Aventis Sa Derives de pyrido[2,3-d] pyrimidine, leur preparation, leur application en therapeutique
FR2896246B1 (fr) 2006-01-13 2008-08-15 Sanofi Aventis Sa Derives de pyrido-pyrimidone, leur preparation, leur application en therapeutique.
FR2910813B1 (fr) * 2006-12-28 2009-02-06 Sanofi Aventis Sa Nouvelle utilisation therapeutique pour le traitement des leucemies
EP2344446A4 (en) 2008-10-17 2012-04-04 Akaal Pharma Pty Ltd S1P RECEPTOR MODULATORS
NZ592748A (en) 2008-10-17 2013-01-25 Akaal Pharma Pty Ltd 2-Amino-(oxadiazol-3-yl)-benzofuran derivatives and their use as S1P receptor modulators
FR2948568B1 (fr) * 2009-07-30 2012-08-24 Sanofi Aventis Formulation pharmaceutique
CN103204827B (zh) * 2012-01-17 2014-12-03 上海科州药物研发有限公司 作为蛋白激酶抑制剂的苯并噻二唑化合物及其制备方法和用途
EP2638911A1 (en) 2012-03-14 2013-09-18 Sanofi Novel combinations for treating acute myeloid leukaemia or chronic myeloid leukaemia
CN103833771A (zh) * 2012-11-22 2014-06-04 天津滨江药物研发有限公司 作为蛋白激酶Mek抑制剂的苯并五元杂环化合物及其制备方法和用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1171218A (en) 1967-11-09 1969-11-19 Parke Davis & Co New Heterocyclic Amine Compounds and Methods for their Production
JPH04128276A (ja) 1990-09-19 1992-04-28 Pfizer Pharmaceut Co Ltd アミノベンゾサルタム誘導体およびその用途
IL115256A0 (en) 1994-11-14 1995-12-31 Warner Lambert Co 6-Aryl pyrido (2,3-d) pyrimidines and naphthyridines and their use
DK0790997T3 (da) 1994-11-14 2000-08-21 Warner Lambert Co 6-Aryl-pyrido[2,3-d]pyrimidiner og napthyridiner til hæmning af protein-tyrosin-kinase-fremkaldt celleproliferation
IL117923A (en) 1995-05-03 2000-06-01 Warner Lambert Co Anti-cancer pharmaceutical compositions containing polysubstituted pyrido¬2,3-d¾pyrimidine derivatives and certain such novel compounds
US5620981A (en) 1995-05-03 1997-04-15 Warner-Lambert Company Pyrido [2,3-D]pyrimidines for inhibiting protein tyrosine kinase mediated cellular proliferation
EE200200405A (et) * 2000-01-25 2003-12-15 Warner-Lambert Company Pürido[2,3-d]pürimidiin-2,7-diamiinid kui kinaasiinhibiitorid
AU2001233028A1 (en) * 2000-03-06 2001-10-03 Warner-Lambert Company 5-alkylpyrido(2,3-D)pyrimidines tyrosine kinase inhibitors
CA2417942C (en) 2000-08-04 2010-06-29 Warner-Lambert Company 2-(4-pyridyl)amino-6-dialkoxyphenyl-pyrido[2,3-d]pyrimidin-7-ones
WO2003000011A2 (en) * 2001-06-21 2003-01-03 Ariad Pharmaceuticals, Inc. Novel pyridopyrimidines and uses thereof
AU2002952453A0 (en) * 2002-11-01 2002-11-21 Novogen Research Pty Ltd Aminated isoflavonoid derivatives and uses thereof
WO2004063195A1 (en) 2003-01-03 2004-07-29 Sloan-Kettering Institute For Cancer Research Pyridopyrimidine kinase inhibitors
TW200502236A (en) * 2003-03-28 2005-01-16 Hoffmann La Roche Novel pyrido[2,3-d]pyrimidin-7-carboxylic acid derivatives, their manufacture and use as pharmaceutical agents
WO2005105097A2 (en) 2004-04-28 2005-11-10 Gpc Biotech Ag Pyridopyrimidines for treating inflammatory and other diseases
FR2873118B1 (fr) 2004-07-15 2007-11-23 Sanofi Synthelabo Derives de pyrido-pyrimidine, leur application en therapeutique
FR2887882B1 (fr) * 2005-07-01 2007-09-07 Sanofi Aventis Sa Derives de pyrido[2,3-d] pyrimidine, leur preparation, leur application en therapeutique
FR2896246B1 (fr) 2006-01-13 2008-08-15 Sanofi Aventis Sa Derives de pyrido-pyrimidone, leur preparation, leur application en therapeutique.
US8338435B2 (en) * 2006-07-20 2012-12-25 Gilead Sciences, Inc. Substituted pyrido(3,2-D) pyrimidines and pharmaceutical compositions for treating viral infections

Also Published As

Publication number Publication date
SI2020410T1 (sl) 2014-04-30
CN101213196A (zh) 2008-07-02
IL187900A0 (en) 2008-03-20
MX2007016239A (es) 2008-03-06
CR9568A (es) 2008-02-20
PL2020410T3 (pl) 2014-05-30
EP2020410A1 (fr) 2009-02-04
ES2322101T3 (es) 2009-06-16
CA2610794A1 (fr) 2007-01-11
CN102260258B (zh) 2015-01-07
CA2610794C (fr) 2012-02-21
RS53211B (en) 2014-08-29
DE602006005246D1 (de) 2009-04-02
FR2887882A1 (fr) 2007-01-05
EP1902054A1 (fr) 2008-03-26
AR054812A1 (es) 2007-07-18
NO20080418L (no) 2008-03-28
US8008310B2 (en) 2011-08-30
PE20070139A1 (es) 2007-03-07
SI1902054T1 (sl) 2009-06-30
PT1902054E (pt) 2009-04-22
AU2006264801A1 (en) 2007-01-11
HRP20140246T1 (hr) 2014-06-20
ZA200711032B (en) 2009-04-29
TNSN07440A1 (en) 2009-03-17
ME01813B (me) 2014-09-20
US20080176874A1 (en) 2008-07-24
PT2020410E (pt) 2014-03-20
KR101298344B1 (ko) 2013-08-20
WO2007003765A1 (fr) 2007-01-11
US20090163522A1 (en) 2009-06-25
ES2450067T3 (es) 2014-03-21
MY143089A (en) 2011-03-15
NZ564072A (en) 2012-02-24
CN102260258A (zh) 2011-11-30
CN101213196B (zh) 2011-09-07
EA200800223A1 (ru) 2008-06-30
KR20080021714A (ko) 2008-03-07
PL1902054T3 (pl) 2009-07-31
EA014312B1 (ru) 2010-10-29
HK1122797A1 (en) 2009-05-29
UA92021C2 (ru) 2010-09-27
EP2020410B1 (fr) 2013-12-18
UY29645A1 (es) 2007-01-31
AU2006264801B2 (en) 2012-05-10
DK2020410T3 (en) 2014-03-24
FR2887882B1 (fr) 2007-09-07
CY1110457T1 (el) 2015-04-29
CY1114989T1 (el) 2016-12-14
US7504406B2 (en) 2009-03-17
TWI321566B (en) 2010-03-11
JO2550B1 (en) 2010-09-05
JP2008544975A (ja) 2008-12-11
TW200745102A (en) 2007-12-16
BRPI0613020A2 (pt) 2010-12-14
PA8684801A1 (es) 2007-01-17
JP4472009B2 (ja) 2010-06-02
ECSP078011A (es) 2008-01-23
MA29561B1 (fr) 2008-06-02
DOP2006000145A (es) 2008-01-31
EP1902054B1 (fr) 2009-02-18
RS50781B (sr) 2010-08-31
ATE423119T1 (de) 2009-03-15
HRP20090236T1 (en) 2009-05-31

Similar Documents

Publication Publication Date Title
IL197352A0 (en) 2-aryl-6-phenylimidazo[1,2-a]pyridine derivatives, preparation thereof and therapeutic use thereof
IL180284A0 (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
DK1902054T3 (da) Pyrido[2,3-d]pyrimidinderivater, fremstilling og terapeutisk anvendelse heraf
IL178402A0 (en) 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof
HK1103730A1 (en) Pyrrolopyridine derivatives and their use as crth2antagonists
IL186881A (en) Pyrido derivatives [3,2– d] pyrimidine and their uses for the manufacture of drugs against hcv
IL180682A0 (en) N-hydroxamide derivatives, their preparation and use
EP1863811A4 (en) IMIDAZO [1,2-A] PYRIDINE DERIVATIVES: PREPARATION AND PHARMACEUTICAL APPLICATIONS
IL180770A0 (en) Oxopiperidine derivatives, preparation and therapeutic use thereof
NO20054331D0 (no) Substituerte-8-perfluoralkyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on-derivater
ZA200703876B (en) 2-amido -4-phenylthiazole derivatives, the preparation and therapeutic use thereof
TWI350287B (en) Acylaminothiazole derivatives, their preparation and their therapeutic application
EP1961753A4 (en) DERIVATIVES OF PIRAZOLOPYRIMIDINONE, THEIR PREPARATION AND USE
IL180797A0 (en) Amino-tropane derivatives, preparation thereof and therapeutic use thereof
DK1590321T3 (da) Arylalkylcarbamat-derivater, fremstilling og terapeutisk anvendelse deraf
IL190519A0 (en) 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof
IL182385A0 (en) Pyridine derivatives and the preparation and the therapeutic use thereof
IL180867A0 (en) Pyrrole derivatives, their preparation and their therapeutic use
DK1742947T3 (da) 6-substituerede pyridoindolanderivater, fremstilling og terapeutisk anvendelse heraf
IL188185A0 (en) Phenylpyridine derivatives, their manufacture and use as pharmaceutical agents
TWI340642B (en) Acylaminothiazole derivatives, preparation and therapeutic application thereof
HK1107340A1 (en) 4-arylmorpholin-3-one derivatives, preparation and therapeutic use thereof
SG150544A1 (en) Novel dichloro-phenyl-pyrido [2,3-d] pyrimidine derivatives, their manufacture and use as pharmaceutical agents